Woods, B. S., Sideris, E., Sydes, M. R., Gannon, M. R., Parmar, M. K., Alzouebi, M., . . . Sculpher, M. J. (2018). Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness. Eur Urol Oncol.
Chicago Style aipamenaWoods, Beth S., et al. "Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness." Eur Urol Oncol 2018.
MLA aipamenaWoods, Beth S., et al. "Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness." Eur Urol Oncol 2018.